Literature DB >> 14723958

Synthesis, biological evaluation, and structural studies on N1 and C5 substituted cycloalkyl analogues of the pyrazole class of CB1 and CB2 ligands.

Mathangi Krishnamurthy1, Wei Li, Bob M Moore.   

Abstract

A series of N1 and C5 substituted cycloalkyl and C5 4-methylphenyl analogues of the N-(piperidin-1-yl)-4-methyl-1H-pyrazole-3-carboxamide class of cannabinoid ligands were synthesized. The analogues were evaluated for CB1 and CB2 receptor binding affinities and receptor subtype selectivity. The effects of pyrazole substitution on ligand conformation and as such receptor affinities was not readily apparent; therefore, the geometries of the N1 and C5 substituents relative to the pyrazole ring were studied using high field NMR spectroscopy and systematic molecular mechanics geometry searches. An analysis of the relative ring geometries and functional group orientations provides new insight into the structural requirements of the CB1 and CB2 ligand binding pocket.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723958     DOI: 10.1016/j.bmc.2003.10.045

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  7 in total

1.  In silico investigation of interactions between human cannabinoid receptor-1 and its antagonists.

Authors:  Guanglin Kuang; Guoping Hu; Xianqiang Sun; Weihua Li; Guixia Liu; Yun Tang
Journal:  J Mol Model       Date:  2012-03-09       Impact factor: 1.810

Review 2.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

Review 3.  Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.

Authors:  Zheng-Xiong Xi; Eliot L Gardner
Journal:  Curr Drug Abuse Rev       Date:  2008-11

4.  3-(4-Bromo-phen-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde.

Authors:  R Prasath; P Bhavana; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-09-17

5.  3-(4-Meth-oxy-phen-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde.

Authors:  R Prasath; P Bhavana; Seik Weng Ng; Edward R T Tiekink
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-10-12

6.  5-Amino-3-anilino-1H-pyrazole-4-carbonitrile.

Authors:  Shaaban K Mohamed; Mehmet Akkurt; Frank R Fronczek; Mahmoud A A El-Remaily; Antar A Abdelhamid
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-08-25

7.  Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results.

Authors:  Cristina Fernández-Fernández; Luis F Callado; Rocío Girón; Eva Sánchez; Amaia M Erdozain; José Antonio López-Moreno; Paula Morales; Fernando Rodríguez de Fonseca; Javier Fernández-Ruiz; Pilar Goya; J Javier Meana; M Isabel Martín; Nadine Jagerovic
Journal:  Drug Des Devel Ther       Date:  2014-02-20       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.